Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1965 1
1966 2
1967 1
1968 2
1969 1
1970 1
1972 1
1973 4
1974 4
1975 14
1976 12
1977 10
1978 6
1979 12
1980 18
1981 15
1982 21
1983 30
1984 20
1985 25
1986 26
1987 21
1988 25
1989 35
1990 22
1991 24
1992 40
1993 38
1994 38
1995 38
1996 42
1997 52
1998 54
1999 57
2000 59
2001 50
2002 49
2003 68
2004 69
2005 85
2006 77
2007 85
2008 108
2009 113
2010 131
2011 130
2012 169
2013 172
2014 181
2015 202
2016 198
2017 222
2018 247
2019 230
2020 276
2021 280
2022 267
2023 258
2024 118

Text availability

Article attribute

Article type

Publication date

Search Results

3,976 results

Results by year

Filters applied: . Clear all
Page 1
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. Ommen SR, et al. Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20. Circulation. 2020. PMID: 33215938 Free article. Review.
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting do …
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorit …
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. Ommen SR, et al. Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20. Circulation. 2020. PMID: 33215931 Free article. Review. No abstract available.
Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
Hathaway J, Heliö K, Saarinen I, Tallila J, Seppälä EH, Tuupanen S, Turpeinen H, Kangas-Kontio T, Schleit J, Tommiska J, Kytölä V, Valori M, Muona M, Sistonen J, Gentile M, Salmenperä P, Myllykangas S, Paananen J, Alastalo TP, Heliö T, Koskenvuo J. Hathaway J, et al. BMC Cardiovasc Disord. 2021 Mar 5;21(1):126. doi: 10.1186/s12872-021-01927-5. BMC Cardiovasc Disord. 2021. PMID: 33673806 Free PMC article.
BACKGROUND: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. ...
BACKGROUND: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. ...
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM. Lopes LR, et al. Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28. Heart. 2015. PMID: 25351510 Free PMC article.
OBJECTIVE: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical decision-making in hypertrophic cardiomyopathy (HCM). ...Patients with SP variants were characterised by younger age and higher pr …
OBJECTIVE: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical deci …
Fully Automated Echocardiogram Interpretation in Clinical Practice.
Zhang J, Gajjala S, Agrawal P, Tison GH, Hallock LA, Beussink-Nelson L, Lassen MH, Fan E, Aras MA, Jordan C, Fleischmann KE, Melisko M, Qasim A, Shah SJ, Bajcsy R, Deo RC. Zhang J, et al. Circulation. 2018 Oct 16;138(16):1623-1635. doi: 10.1161/CIRCULATIONAHA.118.034338. Circulation. 2018. PMID: 30354459 Free PMC article.
Results were evaluated through comparison to manual segmentation and measurements from 8666 echocardiograms obtained during the routine clinical workflow. Finally, we developed models to detect 3 diseases: hypertrophic cardiomyopathy, cardiac amyloid, and pulmonary …
Results were evaluated through comparison to manual segmentation and measurements from 8666 echocardiograms obtained during the routine clin …
Risk stratification in cardiomyopathy.
Sinagra G, Carriere C, Clemenza F, Minà C, Bandera F, Zaffalon D, Gugliandolo P, Merlo M, Guazzi M, Agostoni P. Sinagra G, et al. Eur J Prev Cardiol. 2020 Dec;27(2_suppl):52-58. doi: 10.1177/2047487320961898. Eur J Prev Cardiol. 2020. PMID: 33238741 Free PMC article. Review.
Cardiopulmonary exercise testing provides additional prognostic information, particularly in the setting of heart failure. Cardiopulmonary exercise testing data, integrated in scores such as the Metabolism Exercise Cardiac Kidney Index score have been shown to impro …
Cardiopulmonary exercise testing provides additional prognostic information, particularly in the setting of heart failure. Cardiopulmonary e …
Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy.
Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Bos JM, et al. Mayo Clin Proc. 2014 Jun;89(6):727-37. doi: 10.1016/j.mayocp.2014.01.025. Epub 2014 May 1. Mayo Clin Proc. 2014. PMID: 24793961 Free PMC article.
OBJECTIVES: To determine the prevalence and spectrum of mutations and genotype-phenotype relationships in the largest hypertrophic cardiomyopathy (HCM) cohort to date and to provide an easy, clinically applicable phenotype-derived score that provides a pretes …
OBJECTIVES: To determine the prevalence and spectrum of mutations and genotype-phenotype relationships in the largest hypertrophic …
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.
Murphy SL, Anderson JH, Kapplinger JD, Kruisselbrink TM, Gersh BJ, Ommen SR, Ackerman MJ, Bos JM. Murphy SL, et al. J Cardiovasc Transl Res. 2016 Apr;9(2):153-61. doi: 10.1007/s12265-016-9681-5. Epub 2016 Feb 25. J Cardiovasc Transl Res. 2016. PMID: 26914223 Free PMC article.
Genetic testing for hypertrophic cardiomyopathy (HCM) can provide an important clinical marker for disease outcome and family screening. ...Cochran-Armitage analysis showed similar, statistically significant trends of increased yields for higher genotype scores …
Genetic testing for hypertrophic cardiomyopathy (HCM) can provide an important clinical marker for disease outcome and family …
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy.
Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H. Solomon Z, et al. Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):125-128. doi: 10.1053/j.semtcvs.2018.02.034. Epub 2018 Mar 7. Semin Thorac Cardiovasc Surg. 2018. PMID: 29524602 Review.
3,976 results